Form 4: Eastman Chemical Co Director David W. Raisbeck Reports Changes in Beneficial Ownership

Director David W. Raisbeck reports acquisition of phantom stock units through deferral of director's fees.

Summary

• On October 7, 2024, David W. Raisbeck, a director of Eastman Chemical Co, acquired 277 phantom stock units.
• These units were credited under the Directors' Deferred Compensation Plan, representing a deferral of a portion of the director's annual retainer fees.
• Each phantom stock unit has a value equal to one share of Eastman Chemical Co common stock and is payable in cash after termination of service as a director.
• Following the transaction, Raisbeck beneficially owns 51,654 phantom stock units, which includes 775 units credited since April 5, 2024, as hypothetical reinvestment of dividend equivalents.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to director compensation, which is generally viewed neutrally to positively as it aligns director interests with shareholders.

Positives

• The acquisition of phantom stock units aligns the director's interests with the long-term performance of the company.
• The Directors' Deferred Compensation Plan allows directors to accumulate shares over time.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance.

Industry Context

Directors often receive stock-based compensation to align their interests with shareholders and incentivize long-term value creation. Deferred compensation plans are a common way to provide this.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning the director's interests with the company's long-term performance.

Key Dates